AcouSort
3.12
SEK
-6.31 %
Less than 1K followers
ACOU
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
AcouSort is active within medical technology. The company conducts research and development in a proprietary platform technology that utilises ultrasound to separate and analyse composition of biological cells. The technology is mainly used in the analysis of various cases of cancer as well as sepsis. Part of the research is done together with other stakeholders within field. The company was founded in 2010 and is based in Lund.
Read moreMarket cap
66.03M SEK
Turnover
180.53K SEK
Revenue
4.74M
EBIT %
-340.3 %
P/E
-
Dividend yield-%
-
Financial calendar
18/6
2025
General meeting '25
27/8
2025
Interim report Q2'25
26/11
2025
Interim report Q3'25
All
Press releases
3rd party
ShowingAll content types
AcouSort selected for panel participation at BIO 2025
Redeye: AcouSort Q1 - In line with estimates
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools